title: On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.
abstract: Plant cell culture is emerging as an alternative bioproduction system for recombinant pharmaceuticals. Growing plant cellsin vitrounder controlled environmental conditions allows for precise control over cell growth and protein production, batch-to-batch product consistency and a production process aligned with current good manufacturing practices. With the recent US FDA approval and commercialization of the world's first plant cell-based recombinant pharmaceutical for human use, β-glucocerebrosidase for treatment of Gaucher's disease, a new era has come in which plant cell culture shows high potential to displace some established platform technologies in niche markets. This review updates the progress in plant cell culture processing technology, highlights recent commercial successes and discusses the challenges that must be overcome to make this platform commercially viable.
authors.affiliation: Arkansas Biosciences Institute, Arkansas State University, Jonesboro, AR 72401, USA ; College of Agriculture & Technology, Arkansas State University, Jonesboro, AR 72401, USA.
authors.forename: Jianfeng
authors.initials: J
authors.lastname: Xu
authors.affiliation: Arkansas Biosciences Institute, Arkansas State University, Jonesboro, AR 72401, USA.
authors.forename: Ningning
authors.initials: N
authors.lastname: Zhang